Intra-host viral variability in children clinically infected with H1N1 (2009) pandemic influenza.

The research focuses on the genetic variability within individual human hosts infected with H1N1 (2009) pandemic influenza virus, studying patterns of diversity in the virus’ main genes and analyzing the possibility of multiple infections and low frequency drug-resistant mutations in untreated patients.

Overview of the Study

• This research was conducted to gain insight into the genetic diversity of the H1N1 (2009) influenza virus within individual human hosts. The scientists focused particularly on the hæmagglutinin and neuraminidase genes of the virus, which are key to its ability to infect cells and spread within an organism.
• The study also aimed to understand the dynamics of viral evolution by examining potential cases of co-infection, where a host is infected by multiple strains of the same virus, and the presence of drug-resistant variants in patients not treated with antiviral drugs.

Methodology

• The researchers used a technique called 454 pyrosequencing for this study. This is a type of next-generation sequencing technology that allows for the deep sequencing of genomes, meaning it can accurately detect changes in an organism’s DNA, including small fractions of a population within a host.
• By applying this technique to samples from human clinical cases of H1N1 (2009), the researchers could analyze the full-length viral hæmagglutinin and neuraminidase genes to detect genetic diversity and changes in the viral population.

Findings

• Using 454 pyrosequencing, the researchers observed unexpected patterns of co-infection in a 3-week-old baby. These revealed that more than one strain of the virus was present, a rapid and complex phenomenon known as viral reassortment. This process can lead to the emergence of new viral strains within a single host, contributing to rapid viral evolution and potentially complicating treatment efforts.
• The study also found evidence suggesting the potential existence of very infrequent drug-resistant mutations in the influenza virus in two untreated patients. These rare variants could have the potential to become dominant within the viral population if circumstances change (e.g., in the presence of a drug).

Conclusion and Implications

• In addition to their specific findings, the study also highlighted the technical challenges in studying topics such as homologous recombination, where genetic material is exchanged between different strains, and the detection of rare drug-resistant variants in the viral population.
• This research has important implications for understanding the evolution of influenza viruses and for treatment strategies, underlining the need for further research into these aspects of influenza epidemiology.